These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22115349)

  • 21. Imbalance of endogenous homocysteine and hydrogen sulfide metabolic pathway in essential hypertensive children.
    Chen L; Ingrid S; Ding YG; Liu Y; Qi JG; Tang CS; DU JB
    Chin Med J (Engl); 2007 Mar; 120(5):389-93. PubMed ID: 17376309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for distinct effects of GH and IGF-I in the metabolic syndrome.
    Maison P; Balkau B; Souberbielle JC; Cunin P; Vol S; Macquin-Mavier I; Eschwège E;
    Diabet Med; 2007 Sep; 24(9):1012-8. PubMed ID: 17535291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrogen sulfide in the pathogenesis of atherosclerosis and its therapeutic potential.
    Lynn EG; Austin RC
    Expert Rev Clin Pharmacol; 2011 Jan; 4(1):97-108. PubMed ID: 22115351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood pressure control: hydrogen sulfide, a new gasotransmitter, takes stage.
    Zoccali C; Catalano C; Rastelli S
    Nephrol Dial Transplant; 2009 May; 24(5):1394-6. PubMed ID: 19228755
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiovascular remodeling and metabolic abnormalities in SHRSP.Z-Lepr(fa)/IzmDmcr rats as a new model of metabolic syndrome.
    Ueno T; Takagi H; Fukuda N; Takahashi A; Yao EH; Mitsumata M; Hiraoka-Yamamoto J; Ikeda K; Matsumoto K; Yamori Y
    Hypertens Res; 2008 May; 31(5):1021-31. PubMed ID: 18712058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gasotransmitter hydrogen sulfide in hemodialysis patients.
    Perna AF; Sepe I; Lanza D; Capasso R; Di Marino V; De Santo NG; Ingrosso D
    J Nephrol; 2010; 23 Suppl 16():S92-6. PubMed ID: 21170893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrogen sulfide: its production, release and functions.
    Kimura H
    Amino Acids; 2011 Jun; 41(1):113-21. PubMed ID: 20191298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ghrelin in Type 2 diabetes mellitus and metabolic syndrome.
    Ukkola O
    Mol Cell Endocrinol; 2011 Jun; 340(1):26-8. PubMed ID: 21419192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women.
    Nabipour I; Kalantarhormozi M; Larijani B; Assadi M; Sanjdideh Z
    Metabolism; 2010 May; 59(5):742-7. PubMed ID: 19922962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
    Yki-Järvinen H
    Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging aspects of pharmacotherapy for obesity and metabolic syndrome.
    Nisoli E; Carruba MO
    Pharmacol Res; 2004 Nov; 50(5):453-69. PubMed ID: 15458765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cysteine and hydrogen sulphide in the regulation of metabolism: insights from genetics and pharmacology.
    Carter RN; Morton NM
    J Pathol; 2016 Jan; 238(2):321-32. PubMed ID: 26467985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An outlook on vascular hydrogen sulphide effects, signalling, and therapeutic potential.
    Popov D
    Arch Physiol Biochem; 2013 Dec; 119(5):189-94. PubMed ID: 23808525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Hydrogen Sulfide in Systemic and Pulmonary Hypertension: Cellular Mechanisms and Therapeutic Implications.
    Brampton J; Aaronson PI
    Cardiovasc Hematol Agents Med Chem; 2016; 14(1):4-22. PubMed ID: 26830724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological modulation of the hydrogen sulfide (H
    Piragine E; Calderone V
    Phytother Res; 2021 Apr; 35(4):1817-1846. PubMed ID: 33118671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydrogen sulphide: biopharmacological roles in the cardiovascular system and pharmaceutical perspectives.
    Martelli A; Testai L; Marino A; Breschi MC; Da Settimo F; Calderone V
    Curr Med Chem; 2012; 19(20):3325-36. PubMed ID: 22680638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases.
    Meng G; Ma Y; Xie L; Ferro A; Ji Y
    Br J Pharmacol; 2015 Dec; 172(23):5501-11. PubMed ID: 25204754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redox biochemistry of hydrogen sulfide.
    Kabil O; Banerjee R
    J Biol Chem; 2010 Jul; 285(29):21903-7. PubMed ID: 20448039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beyond blood sugar: the potential of NMR-based metabonomics for type 2 human diabetes, and the horse as a possible model.
    Hodavance MS; Ralston SL; Pelczer I
    Anal Bioanal Chem; 2007 Jan; 387(2):533-7. PubMed ID: 17131108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.